Access to healthcare and harm reduction services during the COVID-19 pandemic for people who use drugs

Stowe, M. J. and Calvey, Tanya and Scheibein, Florian and Arya, Sidharth and Saad, Noha Ahmed and Shirasaka, Tomohiro and Dannatt, Lisa and Ghosh, Abhishek and Yee, Anne and Ratta-Apha, Woraphat and Vadivel, Ramyadarshni and Siste, Kristiana and Shah, Bigya and Ramalho, Rodrigo and Narasimha, Venkata Lakshmi and Delic, Mirjana and Peyron, Eric and Gumikiriza-Onoria, Joy Louise and Pant, Sagun Ballav and Boujraf, Said and Grandinetti, Paolo and Morgan, Nirvana (2020) Access to healthcare and harm reduction services during the COVID-19 pandemic for people who use drugs. Journal of Addiction Medicine, 14 (6). E287-E289. ISSN 1932-0620, DOI https://doi.org/10.1097/ADM.0000000000000753.

Full text not available from this repository.

Abstract

Globally, there are concerns about access to healthcare and harm reduction services for people who use drugs (PWUD) during the coronavirus disease 2019 (COVID-19) pandemic. Members from the Network of Early Career Professionals working in Addiction Medicine shared their experiences of providing treatment to PWUD during the COVID-19 pandemic. Drawing on these qualitative reports, we highlight the similarities and discrepancies in access to services for PWUD in 16 countries under COVID-10 restrictions. In most countries reported here, efforts have been made to ensure continued access to services, such as mobilising opioid agonist maintenance treatment and other essential medicines to patients. However, due to travel restrictions and limited telemedicine services, several Network of Early Career Professionals working in Addiction Medicine members from lower-resourced countries experienced challenges with providing care to their patients during periods of COVID-19 lock-down. The insights provided in this commentary illustrate how the COVID-19 lock-down restrictions have impacted access to services for PWUD.

Item Type: Article
Funders: UNSPECIFIED
Uncontrolled Keywords: Addiction services; Coronavirus disease 2019; Drug use; Opioid agonist maintenance treatment; People who use drugs
Subjects: R Medicine > R Medicine (General)
Divisions: Faculty of Medicine > Psychological Medicine Department
Depositing User: Ms Zaharah Ramly
Date Deposited: 14 Apr 2023 07:18
Last Modified: 14 Apr 2023 07:18
URI: http://eprints.um.edu.my/id/eprint/37171

Actions (login required)

View Item View Item